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 Abstract 
 
Dietary supplementation with omega-3 polyunsaturated fatty acids (PUFAs) containing 
docosahexaenoic (DHA) and eicosapentaenoic acid (EPA) has been demonstrated to produce 
advantageous effects on vascular function.  Specifically, PUFA supplementation has resulted in 
enhanced brachial artery blood flow (Q& ), dilation, and vascular conductance (VC) during 
rhythmic handgrip exercise.  The effects of fish oils (FO) on skeletal muscle blood flow (Q& m) 
during dynamic whole body exercise, however, remain unknown.  PURPOSE: To test our 
hypothesis that 6 weeks of dietary FO supplementation with DHA and EPA enhances regional 
Q& m and VC to the hindlimb musculature during submaximal treadmill exercise.  METHODS:  
Following 6 weeks of dietary supplementation with safflower oil (SO) (control; n = 9) or FO (n =  
8), heart rate (HR), mean arterial pressure (MAP), and Q& m to the hindlimb were measured at rest 
and during submaximal treadmill exercise (20 m/min, 10%, ~65% V. O2max) via radiolabeled  
 
microspheres in adult male Sprague-Dawley rats.  RESULTS: HR and MAP were not different 
between SO and FO at rest or exercise (P<0.05).  Q& m and VC were not different between SO and 
FO at rest.  During exercise, FO exhibited greater Q& m in 8 of the 28 muscle parts measured as 
well as greater VC in 11 of the 28 muscle parts measured.  Additionally, FO exhibited greater 
Q&
m (158±9) and VC (1.156±0.066) to the total hindlimb musculature than SO (128±10 
ml/min/100g, 0.918±0.077 ml/min/100g/mmHg) (P<0.05).  CONCLUSION: These results 
demonstrate that 6 weeks of dietary FO supplementation with DHA and EPA results in enhanced 
Q&
m and VC to the hindlimb during submaximal exercise.  Thus, supplementation with DHA and 
 EPA may have therapeutic effects on oxygen delivery and vascular function in patients with 
impaired vascular function and exercise tolerance (i.e., congestive heart failure, diabetes). 
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CHAPTER 1 - Introduction 
Healthy vascular function helps ensure the blood supply that is crucial for delivery of 
oxygen and substrates required to meet the energetic requirements of exercising skeletal muscle.  
In contrast, vascular dysfunction compromises skeletal muscle function and limits exercise 
tolerance.  Dietary supplementation with fish oils containing the omega-3 polyunsaturated fatty 
acids (PUFAs) docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) improves 
vascular function (24).  In healthy individuals, dietary PUFA supplementation improves 
endothelium-dependent vasodilation and enhances skeletal muscle blood flow ( Q& m) during 
rhythmic handgrip exercise (24, 47).  Therefore, it is reasonable to pose the question whether 
dietary supplementation with DHA and EPA might also augment Q& m during dynamic, 
locomotory exercise. 
Pertinent to this issue, DHA and EPA have been demonstrated to enhance the production 
and release of nitric oxide (NO) from the vascular endothelium (28, 38). In the rat, dietary 
supplementation with DHA and EPA increases the content of eNOS (endothelial nitric oxide 
synthase) mRNA in the aorta as well as enhancing eNOS expression, eNOS activity, and overall 
NO bioavailability (28).  Increased NO production and release from the vascular endothelium 
could be advantageous because of its potential to increase Q& m and O2 delivery during exercise.   
At exercise onset, Q& m increases rapidly to meet metabolic demands and in highly 
oxidative muscles can achieve values exceeding 40-fold those at rest (9).  While the rapid 
vasodilation within the first contraction cycle is of uncertain origin, NO and other vasoactive 
substances released from the endothelium do contribute to the subsequent sustained elevations of 
Q& m by facilitating terminal arteriolar vasodilation (19, 30, 31, 34).  This dilation ascends from 
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these arterioles to the larger feed arteries and conduit blood vessels located external to the 
skeletal muscle and consequent to this ascending vasodilation, Q& m will continue to increase to 
the contracting muscle (9, 44).  This additional Q& m will produce further increases in shear stress 
on the vascular endothelial cells and thus will generate further increases in Q& m mediated by the 
NO regulatory pathway (41). Therefore, an overall increased bioavailability of NO subsequent to 
DHA and EPA supplementation could plausibly enhance Q& m and O2 delivery to the contracting 
musculature during dynamic exercise. 
Previous studies have assessed the Q& m response to dietary fish oil (FO) supplementation 
at rest, but we do not know whether PUFAs impact Q& m among and within different locomotor 
muscles during exercise.  Following FO supplementation, enhanced endothelium-dependent 
vasodilation, reduced vascular oxidative stress, and augmented Q& m have been demonstrated at 
rest (6, 7, 24).  While Q& m during exercise has also been increased following supplementation, 
the mode of exercise utilized is non-locomotory in nature (i.e., rhythmic handgripping) which 
employs a small muscle mass (47).  Consequently, the effect of dietary PUFA supplementation 
on dynamic locomotory (large muscle mass) exercise remains unknown.   
Given the substantial role of dynamic locomotory exercise to benefit health and quality of 
life, it is important to determine the effects of FO onQ& m and vascular function during whole 
body exercise.  The Sprague-Dawley rat is an accepted model of the human vasculature and 
established microsphere techniques exist for the precise measurement of muscle and regional Q&
 
during running exercise.  This model will allow us to determine the effects of dietary FO 
supplementation (DHA and EPA) on both Q& m and vascular conductance (VC) during dynamic 
locomotory exercise. 
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The primary objective of this study is to test the hypothesis that dietary supplementation 
with fish oils that contain the PUFAs DHA and EPA will enhance the Q& m response to dynamic 
submaximal treadmill exercise in the rat hindlimb.  If dietary supplementation with fish oils 
containing DHA and EPA can enhance Q& m and vascular conductance in healthy individuals 
during exercise, it is plausible that these supplements would also enhance Q& m and VC in those 
patients afflicted with cardiovascular disease.  This would establish a template for the use of 
DHA and EPA supplementation as a potential therapeutic treatment for individuals with 
cardiovascular disease as these diseases often result in a lifestyle-eroding reduction in exercise 
tolerance that may potentially result from a reduced Q& m (23). 
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CHAPTER 2 - Review of Literature 
Regulation of Q& m During Exercise 
During exercise, healthy Q& m and O2 delivery are necessary to meet the metabolic 
demands of the exercising musculature.  At the onset of dynamic exercise, Q& m is increased 
within the first second following contraction and, in healthy individuals, reaches steady-state 
levels within ~30-90 seconds (9).  While this immediate rapid vasodilation within the first 
contraction cycle is of uncertain origin, it is likely that the factors that contribute to it are not the 
same as the ones that sustain Q& m during steady-state exercise. Therefore, this review will focus 
on the factors involved in the regulation of sustained elevations of Q& m during dynamic, steady-
state exercise. 
Metabolic Control 
Muscular contractions result in the production of metabolites that diffuse out of the cell 
into the extracellular fluid (ECF).  These metabolites include NO, prostaglandins (PG), 
adenosine, lactic acid, potassium, inorganic phosphate, and hydrogen ions (9). As muscle 
metabolism increases with increased exercise intensity, the concentration of these metabolites in 
the ECF also increases.  The metabolites can then diffuse to the arterioles where they act upon 
the vascular smooth muscle resulting in a vasodilation of the arteriole that allows for increased 
blood flow (10). Therefore, Q& m is regulated metabolically as it is increased during exercise to 
allow the O2 supply to meet the increased O2 demand of the working musculature. 
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Endothelial Control and Flow-Mediated Dilation 
The vascular endothelium of the arteriole releases vasodilator substances in response to 
various stimuli.  The endothelium possesses the ability to detect both forces on the vessel walls 
and chemical substances within the blood and respond via the release of vasoactive molecules 
such as NO and PG that initiate a vasodilation of the arterioles (40).  This dilation can then 
progress to the feed arteries external to the muscle via ascending vasodilatory mechanisms that 
help to further regulate Q& m to the exercising muscle (9, 44, 49).   
When Q&
 
is increased in the arterioles, it causes increased shear stress on the vascular 
endothelium that results in a further dilation in the vascular resistance vessels (25).  This process 
has been termed flow-mediated dilation and it is currently believed that flow-mediated dilation is 
dependent, at least in part, on the production and release of NO (17).  This concept is supported 
further by Rubanyi and colleagues who have found enhanced production of eNOS in response to 
increases in shear stress (41).  Therefore, during dynamic exercise, the regulation of Q&
 
in both 
the terminal arterioles and the larger feed arteries is thought to be dependent, in part, upon the 
availability of NO. 
Nitric Oxide  
NO is an endogenous signaling molecule that is synthesized by nitric oxide synthase 
(NOS) from the vascular endothelium (eNOS) and sarcolemma and neuromuscular junction of 
skeletal muscle (neuronal NOS) (45).  When released, eNOS initiates a cascade of reactions in 
smooth muscle via a cyclicGMP pathway that activates a cGMP-dependent protein kinase to 
facilitate a reduction in intracellular calcium concentration, decreased calcium-dependent 
phosphorylation of smooth muscle myosin regulatory light chain and thus, relaxation of the 
vascular smooth muscle (16, 26).  The intramuscular location of neuronal NOS (nNOS) at the 
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sarcolemma and neuromuscular junction has led to speculation that upon contraction, it could 
diffuse to smooth muscle cells in the adjacent vasculature, bind to soluble guanylyl cyclase and 
initiate the cGMP relaxation cascade that is seen with eNOS, thus implicating both forms of 
NOS in exercise-induced vasodilation (16, 26).  Arteriolar relaxation has been demonstrated to 
be decreased in contracting muscles of mice lacking either eNOS or nNOS, demarcating a 
potential role for both in the Q& m response seen in contracting muscle (26).  Additionally, a 
follow-up study by Grange and colleagues in 2001 has further evidenced the contribution of NO 
derived from both eNOS and nNOS in the vasodilation of contracting skeletal muscle (16). 
In studies performed in the rat, the Q& m response to NOS inhibition has been 
demonstrated to be dependent on both the muscle groups recruited by the exercise and the fiber  
type composition of the individual muscles (19, 30, 31, 34).  When measured during dynamic 
treadmill exercise (20m/min, 10% grade, ~65%V. O2 max) using the NOS inhibitor L-NAME,  
 
Q& m was decreased in 16 of 28 individual muscles or muscle parts measured, dependent upon 
their fiber type composition (19).  Specifically, Q&
 
was decreased in the individual skeletal 
muscles that contained a large percentage of slow twitch oxidative (SO) and fast twitch oxidative  
glycolytic (FOG) fibers.  This indicates that highly oxidative fibers exhibit greater NO induced-
vasodilation during exercise (19, 30, 31, 34).  Moreover, at running speeds that elicit V. O2 max  
 
(60m/min, 10% grade), vascular conductance (VC;Q&  normalized to mean arterial pressure) is 
also reduced further in muscles composed of more FOG and SO fibers than those composed of 
FG fibers (34).  Consequently, NO availability appears to contribute to the regulation of Q& m 
during dynamic treadmill exercise.  Additionally, the role of NO in Q& m during exercise likely 
varies among muscles with differing fiber types.  
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It is important to note, however, that the effectiveness of L-NAME and other NOS 
inhibitors on NO produced by the skeletal muscles (nNOS) is currently unclear. A limitation of 
the previous studies that have utilized L-NAME to inhibit NOS and determine the role of NO in 
exercise-induced vasodilation is that L-NAME may inhibit NOS produced from the vascular 
endothelium (eNOS), but not the production or release of nNOS from the contracting skeletal 
muscle.  As mentioned previously, eNOS and nNOS have both been implicated in the hyperemic 
blood flow response to exercise.  Therefore, while L-NAME may inhibit NO formation and 
release from the vascular endothelium (eNOS), it is possible that the NO produced in the skeletal 
muscle (nNOS) is not inhibited and may therefore contribute to the exercise-induced vasodilation 
seen during eNOS inhibition thereby masking a larger overall effect of NO.  
Dietary Fish Oil Supplementation 
Dietary supplementation with fish oils containing the omega-3 polyunsaturated fatty 
acids DHA and EPA has been demonstrated to have advantageous effects on the cardiovascular 
system.  These effects are numerous and include reduced vascular oxidative stress and enhanced 
dilation and Q& m.  While FO supplementation has been demonstrated to produce these beneficial 
effects, the mechanism or mechanisms behind these benefits have not been clearly identified.  
Therefore, this review will encompass both the beneficial effects of FO supplementation and the 
potential mechanisms behind these effects. 
 
Nitric Oxide and Prostaglandins 
While the previous literature has shown reductions in vascular oxidative stress, improved 
vascular reactivity, enhanced endothelial function, and enhanced Q&  subsequent to dietary FO 
supplementation, the mechanisms for this enhancement have not been clearly identified.  Lawson 
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et al. examined the treatment of rat aortic rings with EPA and DHA and determined that it results 
in enhanced synthesis or release of EDRF (NO) and PG (27).  In 1997, Okuda et al. investigated 
NO production from endothelial cells following treatment with EPA (38).  Their results 
demonstrated an enhancement in NO production from endothelial cells following the EPA 
treatment (38).  Hishinuma and colleagues later demonstrated that FO supplementation also 
increases bovine endothelial cells’ release of PGI2 (prostacyclin) and PGI3 (prostaglandin I3)(20).  
Application of the results of these studies is somewhat limited, however, for the because the 
endothelial cells were treated directly with EPA and DHA and not by the use of dietary 
supplementation.  
In 2000, Lopez et al. determined that dietary FO supplementation potentiated endothelial 
production of NO in the aorta of Sprague-Dawley rats (29).  In 2004, they followed-up the 
previous study by demonstrating an upregulation of eNOS in the aorta of the rat subsequent to 8 
weeks of supplementation of a diet rich in fish oils (28).  Additionally, they were able to 
demonstrate an enhancement in both NO production and activity subsequent to the 
supplementation (28).  As such, the enhancement of either NO bioavailability, or both NO and 
PG production and release subsequent to fish oil supplementation implicate both as potential 
mechanisms for the improved vascular reactivity, enhanced endothelial function, and augmented 
Q& m.  Furthermore, while the literature has shown enhancement of the bioavailability of eNOS 
subsequent to supplementation, it is not known whether there is a concomitant enhancement in 
nNOS bioavailability. 
Oxidative Stress 
In addition to enhanced Q& m and endothelial function, reductions in oxidative stress have 
also been observed subsequent to FO supplementation.  Oxidative stress is a condition in which 
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reactive oxygen species (ROS) are elevated such that the cells’ antioxidant systems are 
overwhelmed and produce deleterious effects on the vascular endothelium (46).  In 1997, 
Carbonell et al. investigated the effects of 5 weeks of dietary FO supplementation on the 
production of superoxide (O2-), a ROS, in the vasculature and found that O2- production was 
31% less in rats fed FO than in those on the control diet of corn oil (6).  This finding is 
significant because O2- can react with NO to generate other more detrimental ROS such as 
peroxynitrite (ONOO-) that can damage the vasculature (46).  Dietary FO supplementation can 
also enhance superoxide dismutase (SOD) activity in the rat (7).  An enhancement in SOD is 
important because it can react with O2- to form hydrogen peroxide (H2O2), a more stable ROS 
that is enzymatically converted to H2O by catalase or glutathione peroxidase (46).  Similar 
results have been found in type-2 diabetic subjects who received 6 weeks of dietary 
supplementation with fish oils (33).  Oxidative stress was shown to be significantly attenuated 
subsequent to PUFA supplementation (33) and similar results have been found in fructose-fed 
rats when supplemented with fish oils (37).  The results of these studies have led Mori and 
colleagues to suggest that dietary supplementation with the PUFAs EPA and DHA may have a 
positive impact on the redox state in the vasculature of those with cardiovascular disease, thereby 
reducing the stress and endothelial damage caused by the ROS (33).  This could potentially be 
responsible for the beneficial effects of fish oils on cardiovascular health.   
MuscleBlood Flow ( Q& m) 
In healthy populations, dietary FO supplementation has resulted in enhancements in 
vascular reactivity, endothelium-dependent vasodilation, and thus Q& m (8, 24, 47).  In 1992, Chin 
and colleagues established that FO supplementation dose-dependently decreased the 
vasoconstrictive response to the potent constriction induced by norepinephrine (NE) and 
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angiotensin II (Ang II) allowing for improved Q& (8).  The significance of this observation lies in 
the fact both NE and Ang II are implicated in the development of hypertension, which results in 
increased systemic vascular resistance (22).  This finding also reflects the previous literature that 
has shown populations with greater fish consumption tend to have lower incidences of 
hypertension (3).  In a 2003 study, Khan et al. studied the effects of FO supplementation on 
endothelial function and microvascular Q&  in healthy subjects (24).  The results of the study 
illustrated a significant improvement in the endothelial response to acetylcholine (ACh), which is 
a vasodilator of vascular smooth muscle that allows enhanced Q& .  While these results indicate a 
role for FO supplementation in the enhancement of Q&  at rest, supplementation has also been 
evidenced to significantly enhance brachial artery Q&  and VC during rhythmic handgrip exercise 
in healthy subjects (47).  Based on their results, the authors suggested that treatment with fish 
oils could potentially delay the onset of fatigue to the working muscles in healthy individuals 
allowing them to work at a higher workload for a longer period of time (47).  Altogether, these 
results demonstrate the beneficial effects of FO supplementation on Q& m and vascular function in 
healthy subjects. 
Cardiovascular diseases such as hypertension, hypercholesterolemia, type-II diabetes 
mellitus, coronary artery disease, and congestive heart failure (CHF) often result in endothelial 
dysfunction (1, 5, 12, 13, 39, 48).  This endothelial dysfunction may be attributable, in part, to 
increased oxidative stress and reductions in the bioavailability of NO in the vasculature and 
manifests itself as impaired endothelium-dependent vasodilation, increased systemic vascular 
resistance, and decreased vascular reactivity.  These vascular derangements can lead to a 
decreased exercise tolerance and reduced functional capacity in affected individuals.  This 
underscores the importance of resolving the potential for FO supplementation to improve 
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endothelial function.  Consequently, if dietary PUFA supplementation could improve vascular 
endothelial function, activeQ& , and O2 delivery to the skeletal muscle during dynamic exercise 
conditions, then it could plausibly improve both the exercise tolerance and quality of life of 
individuals afflicted with various types of cardiovascular disease. 
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CHAPTER 3 - Methods 
Animal Selection and Care 
Seventeen adult male Sprague-Dawley rats were used in this study.  Rats were 
maintained on a 12-12 hour light-dark cycle and received food and water ad libitum.  All 
experiments were approved under the guidelines established by the Kansas State University 
Institutional Animal Care and Use Committee (IACUC) and conducted under the guiding 
principles of the American Physiological Society (APS) and the National Institutes of Health 
(NIH). 
Dietary Supplementation 
Two groups of rats were studied in the present investigation.  Both groups were fed the 
following diet (expressed as grams/kg diet): Casein 225, cornstarch 446, sucrose 223, cellulose 
31, DL-Methionine 1, standard mineral mix 14, standard vitamin mix 10, oil 50, and alpha-
tocopherol acetate 0.09.  Both diets consisted of 5% oil.  In the control group of rats (Safflower 
Oil, n = 9) 50% of the oil consisted of safflower oil (SO) and in the experimental group of rats 
(Fish Oil, n= 8), 50% of the oil consisted of FO high in docosahexaenoic (~20%) and 
eicosapentaenoic acids (~30%).  Both groups of animals followed their isocaloric dietary 
regimens for a duration of 6 weeks.  A similar diet containing these levels of DHA and EPA has 
previously been reported to increase acetylcholine-induced dilation in the rat aorta (29). 
Treadmill Acclimatization 
All animals were familiarized with running on a motor-driven treadmill according to the 
guidelines described in the Resource Book for the Design of Animal Exercise Protocols as 
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published by the APS (Bethesda, MD).  The animals were brought to the laboratory and placed 
into a lane on the treadmill belt.  The animals were then acclimated to walking on the treadmill.  
During the protocol of familiarization (1-2 weeks), animals exercised for 5-10 minutes/day at a 
speed of 20 meters/minute and a grade of 10%.  The treadmill is equipped with an electric eye 
that, when tripped by the animal, initiates a burst of high-pressured air towards the animal’s 
hindquarters.  This burst of air is considered to be a non-noxious stimulus and is used to 
encourage the animal to stay at the front of the treadmill lane.  If they continue to the back of the 
treadmill lane, the animal will contact a grid designed to deliver an electric shock (20 volts) at a 
very low non-lethal current (0.2 mAmps).  This stimulus is used during acclimatization to 
encourage the animal to keep pace on the treadmill and stay at the front of the lane and is 
typically not contacted by the animal following familiarization, if at all. 
Surgical Procedure 
Once it had been established that all of the rats were proficient runners, each animal was 
anesthetized with a 5% isoflurane and 95% oxygen mixture. Each animal was then maintained 
on a 3% isoflurane and 97% oxygen mixture during acute surgical instrumentation. While the 
animals were maintained at a non-reflexive anesthetic state, as demonstrated by the lack of 
response to painful stimuli (i.e. toe pinch, foot clamp, or incision), the right carotid artery and 
caudal (tail) artery were isolated and cannulated with polyethylene catheters (PE-10 connected to 
PE-50) (Intra-Medic polyethylene tubing; Clay Adams, Sparks, MD).  The carotid artery catheter 
was advanced 2–3 mm rostral to the aortic valve.  The caudal artery catheter was advanced 
toward the bifurcation of the descending aorta.  The carotid and caudal catheters were then 
tunneled subcutaneously to the dorsal aspect of the thorax and exteriorized through a small 
puncture wound in the skin.  This incision was closed with 3-0 silk suture. All wounds were 
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infiltrated with a 0.5% bupivacaine solution to maintain local anesthesia at the surgical sites.  
Isoflurane anesthesia was then terminated and each animal was given > 2 hours to recover.  This 
period of recovery was selected based on a previous study that has shown that hemodynamic, 
arterial blood gas, and acid-base parameters are stable in the awake rat during 1-6 hours of 
recovery from gas anesthesia (14). 
Experimental Protocol 
Subsequent to the recovery period, the final experimental protocol was initiated.  Each 
animal was placed on the treadmill, and following a period of stabilization (~15 minutes), the 
caudal artery catheter was attached to a 1ml plastic syringe connected to a Harvard 
infusion/withdrawal pump (model 907).  The carotid artery catheter was then connected to a 
pressure transducer to measure heart rate and blood pressure.  Exercise was then initiated at a 
speed of 20 meters/minute up a 10% incline.  After ~3 minutes of treadmill exercise, the carotid 
artery catheter was disconnected from the pressure transducer and 0.5x106 radiolabeled 
microspheres (46Sc or  85Sr;  15 microns in diameter; Perkin-Elmer Life Sciences Incorporated, 
Boston, MA) were injected into the aortic arch to determine regional blood flow.  
Simultaneously, blood withdrawal from the caudal artery catheter was initiated at a rate of 0.25 
ml/min. Approximately 30 seconds following the infusion of microspheres, blood withdrawal 
from the caudal artery catheter was stopped, exercise was terminated, and the animal was 
allowed ~60 minutes to recover on the treadmill lane. 
Following the 60 minutes of recovery, the heart rate and blood pressure measurements 
were repeated and a second microsphere infusion was performed following the same procedures 
as above to determine regional blood flow under resting conditions.  This procedure of 
measuring blood flow at rest following exercise minimizes the potential for blood loss to affect 
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the exercise response and allows for “resting” measurements that do not reflect the pre-exercise 
anticipatory state of the animal (2). 
After the blood flow determinations were completed, each animal was removed from the 
treadmill lane and anesthetized with pentobarbital (40 mg/kg i.a.).  An arterial blood sample (0.3 
ml) was taken, and the animal was euthanized with an overdose of pentobarbitol anesthesia (100 
mg/kg i.a.).  Upon confirmation of death, the thorax was opened and placement of the carotid 
artery catheter into the aortic arch was confirmed by anatomical dissection.  The kidneys, 
visceral organs, and muscles of both hindlimbs of the animal were identified, removed, weighed, 
and placed immediately into counting vials.  The radioactivity of each tissue was then 
determined by a gamma-scintillation counter (Packard Auto Gamma Spectrometer, model 5230, 
Downers Grove, IL).  Taking into account the cross-talk fraction between isotopes, blood flow to 
each tissue was determined using the reference sample method and expressed in ml/min/100g 
tissue (35).  Adequate mixing of the microspheres was verified by the demonstration of <15% 
difference in right and left kidney blood flow.  Blood flow measurements were then normalized 
to mean arterial pressure and expressed as vascular conductance (ml/min/100g/mmHg). 
Statistical Analysis 
Heart rate, mean arterial blood pressure, tissue Q& , and tissue VC were compared between 
groups using unpaired Student’s t-tests.  All values are expressed as means ± SEM.  Statistical 
significance was set at P<0.05. 
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CHAPTER 4 - Results 
Fish Oil Effects on Heart Rate and Mean Arterial Pressure 
Heart rate (HR) and mean arterial pressure (MAP) measured at rest were not different 
between FO and SO rats.  While SO and FO rats both exhibited a significantly greater HR during 
exercise than at rest, MAP did not increase above resting values nor did it differ between SO and 
FO rats during the submaximal treadmill exercise (Table 4-1).  
Fish Oil Effects on Blood Flow (Q& ) 
The effects of FO supplementation on theQ& at rest and in response to exercise for the 
splanchnic organs are shown in Figure 4-1.  At rest, SO rats exhibited significantly greater Q&  to 
the large intestine and pancreas than FO rats while there was no difference between SO and FO 
rats in the rest of the organs examined or in total splanchnic Q& .  Q& to the splanchnic organs was 
not different between the SO and FO rats during exercise (lower panel Figure 4-1).   
Q& m to the total hindlimb musculature measured at rest was not significantly different 
between the SO and FO rats (upper panel Figure 4-2) nor was it significantly different for any of 
the 28 hindlimb muscles or muscle parts examined (Table 4-2).  However, during exercise, the 
FO rats exhibited a 23% greater Q& m to the total hindlimb musculature (FO, 158±9: SO, 128±10 
ml/min/100g, P<0.05) (lower panel Figure 4-2).  This reflected, in part, a significantly higher 
Q& m in 8 of the 28 muscles or muscle parts in the FO compared with the SO rats (Table 4-3, 
upper panel Figure 4-3).  
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Fish Oil Effects on Vascular Conductance (VC) 
Although there was no significant difference in MAP between SO and FO rats, results 
were also examined and expressed as VC.  The effects of FO supplementation on the VC during 
exercise for the splanchnic organs are shown in Figure 4-4.  At rest, SO rats exhibited 
significantly greater VC to the large intestine and pancreas than FO rats while there was no 
difference between SO and FO rats in the rest of the organs examined (upper panel Figure 4-4).  
VC to the splanchnic organs was not different between the SO and FO rats during exercise 
(lower panel Figure 4-4).   
VC to the total hindlimb musculature measured at rest was not significantly different 
between the SO and FO rats, nor was it significantly different for any of the 28 hindlimb muscles 
or muscle parts examined (Table 4-4, upper panel Figure 4-5).  During exercise, however, the FO 
rats demonstrated 26% greater VC to the total hindlimb musculature than SO rats (FO, 
1.156±0.066; SO, 0.918±0.077 ml/min/100g/mmHg, P<0.05) (lower panel Figure 4-5).  
Additionally, VC was significantly higher than SO in 11 of the 28 hindlimb muscles or muscle 
parts in the FO compared to the SO rats (Table 4-5, lower panel Figure 4-3).   
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Table 4-1 Heart Rate and Mean Arterial Pressure 
Heart rate measured at rest and during submaximal treadmill exercise in rats fed a diet supplemented with Safflower 
Oil (Control) and Fish Oil.  Values are means ± SE, † P< 0.05 vs. Rest 
 
 
 
      HR (bpm)   MAP (mmHg) 
 
Safflower Oil  
Rest      417±5    140±3 
Exercise      500±6†    141±3 
 
Fish Oil 
Rest      412±11    137±3 
Exercise      492±7†    136±1 
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Table 4-2 Resting Muscle Blood Flow 
 
Blood flow (ml/min/100g) measured at rest in all hindlimb muscles of rats fed a diet supplemented with Safflower 
Oil and Fish Oil for which there was no effect of Fish Oil.  Values are means + SE.  
 
 
      Safflower Oil  Fish Oil 
Ankle extensors 
Soleus     120±19   94±24 
Plantaris     12±2   21±9
 
Gastrocnemius 
 Red     24±3   37±16 
 White     17±4   17±3 
 Middle     12±2   17±7 
Tibialis posterior     29±8   23±7 
Flexor digitorum longus    49±17   51±7 
Flexor hallicus longus    13±3   20±8 
Ankle flexors 
Tibialis anterior      
 Red     50±14   59±19 
 White     23±5   27±9 
Extensor digitorum longus    22±5   32±13 
Peroneals     16±4   23±8 
Knee extensors 
 Vastus intermedius    81±18   93±26 
 Vastus medialis     13±2   26±10 
 Vastus lateralis 
  Red     85±18   89±35 
  White     16±5   18±7 
  Middle     25±5   27±11 
 Rectus Femoris 
  Red     19±5   49±18 
  White     16±4   24±8 
Knee flexors 
Biceps femoris 
 Anterior     10±2   15±7 
 Posterior     12±3   13±5 
Semitendinosus     11±2   14±4 
Semimembranosus     
 Red     15±3   19±8 
 White     12±2   15±5 
Thigh adductors 
Adductor longus     123±20   143±20 
Adductor magnus & brevis    14±2   21±8 
Gracilis     14±2   15±3 
Pectineus     35±11   38±15 
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Table 4-3 Exercise Muscle Blood Flow 
 
 
 
      Safflower Oil  Fish Oil 
Ankle extensors 
Soleus     250±34   330±28* 
Plantaris     222±31   263±26
 
Gastrocnemius 
 Red     453±67   515±54 
 White     45±7   70±12* 
Middle     184±25   232±20 
Tibialis posterior     198±23   263±33 
Flexor digitorum longus    83±18   122±12 
Flexor hallicus longus    116±16   158±15* 
Ankle flexors 
Tibialis anterior      
 Red     289±32   373±38 
 White     110±18   124±13 
Extensor digitorum longus    76±14   92±11 
Peroneals     109±16   141±16 
Knee extensors 
 Vastus intermedius    418±52   500±47 
 Vastus medialis     152±17   225±37* 
Vastus lateralis 
  Red     407±53   414±44 
  White     92±42   85±16 
  Middle     242±29   251±24 
 Rectus Femoris 
  Red     277±35   360±30* 
  White     131±14   171±16* 
Knee flexors 
Biceps femoris 
 Anterior     76±10   97±13 
 Posterior     94±10   117±10 
Semitendinosus     46±5   59±9 
Semimembranosus     
 Red     175±19   215±22 
 White     48±5   74±9* 
Thigh adductors 
Adductor longus     247±58   450±74* 
Adductor magnus & brevis    102±10   126±14 
Gracilis     38±6   69±17 
Pectineus     36±8   51±13 
___________________________________________________________________________________________________________________ 
 
 
 
Blood flow (ml/min/100g) measured during submaximal treadmill exercise in all hindlimb muscles of rats fed a diet 
supplemented with Safflower Oil and Fish Oil.  Values are means + SE.  *P< 0.05 compared to SO. 
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Table 4-4 Resting Muscle Vascular Conductance 
 
 
      Safflower Oil  Fish Oil 
Ankle extensors 
Soleus     0.857±0.139  0.696±0.182 
Plantaris     0.087±0.019  0.154±0.071
 
Gastrocnemius 
 Red     0.171±0.025  0.272±0.124 
 White     0.123±0.027  0.124±0.021 
 Middle     0.084±0.015  0.124±0.051 
Tibialis posterior     0.207±0.057  0.168±.051 
Flexor digitorum longus    0.357±0.128  0.373±0.057 
Flexor hallicus longus    0.095±0.022  0.147±0.062 
Ankle flexors 
Tibialis anterior      
 Red     0.363±0.099  0.433±0.144 
 White     0.163±0.037  0.197±0.065 
Extensor digitorum longus    0.156±0.037  0.239±0.098 
Peroneals     0.116±0.032  0.166±0.061 
Knee extensors 
 Vastus intermedius    0.580±0.132  0.685±0.195 
 Vastus medialis     0.091±0.017  0.195±0.077 
 Vastus lateralis 
  Red     0.613±0.135  0.649±0.261 
  White     0.112±0.034  0.133±0.052 
  Middle     0.178±0.038  0.200±0.085 
 Rectus Femoris 
  Red     0.138±0.037  0.357±0.138 
  White     0.114±0.029  0.178±0.060 
Knee flexors 
Biceps femoris 
 Anterior     0.568±0.059  0.651±0.081 
 Posterior     0.083±0.020  0.097±0.035 
Semitendinosus     0.078±0.014  0.101±0.032 
Semimembranosus     
 Red     0.110±0.027  0.140±0.063 
 White     0.084±0.012  0.108±0.041 
Thigh adductors 
Adductor longus     0.873±0.146  1.053±0.153 
Adductor magnus & brevis    0.102±0.018  0.156±0.059 
Gracilis     0.100±0.015  0.113±0.026 
Pectineus     0.256±0.079  0.284±0.115 
 
 
Vascular conductance (ml/min/100g/mmHg) measured at rest in all hindlimb muscles of rats fed a diet 
supplemented with Safflower Oil and Fish Oil for which there was no effect of Fish Oil.  Values are means + SE. 
 22 
Table 4-5 Exercise Muscle Vascular Conductance 
 
 
 
      Safflower Oil  Fish Oil 
Ankle extensors 
Soleus     1.791±0.248  2.432±0.220* 
Plantaris     1.584±0.221  1.925±0.185
 
Gastrocnemius 
 Red     3.223±0.128  3.785±0.410 
 White     0.326±0.058  0.513±0.081* 
Middle     1.311±0.185  1.705±0.145 
Tibialis posterior     1.418±0.173  1.920±0.2331 
Flexor digitorum longus    0.593±0.130  0.890±0.089* 
Flexor hallicus longus    0.832±0.121  1.160±0.114* 
Ankle flexors 
Tibialis anterior      
 Red     2.074±0.258  2.749±0.300 
 White     0.794±0.143  0.911±0.098 
Extensor digitorum longus    0.551±0.107  0.672±0.078 
Peroneals     0.779±0.120  1.041±0.127 
Knee extensors 
 Vastus intermedius    2.986±0.382  3.670±.0351 
 Vastus medialis     1.085±0.128  1.639±0.264* 
Vastus lateralis 
  Red     2.909±0.390  3.041±.0333 
  White     0.634±0.273  0.616±0.112 
  Middle     1.732±0.219  1.835±0.171 
 Rectus Femoris 
  Red     1.986±0.268  2.649±0.232* 
  White     0.939±0.102  1.256±0.118* 
Knee flexors 
Biceps femoris 
 Anterior     0.609±0.033  0.712±0.093 
 Posterior     0.673±0.085  0.857±0.079 
Semitendinosus     0.327±0.040  0.433±0.065 
Semimembranosus     
 Red     1.253±0.148  1.579±0.162* 
 White     0.343±0.043  0.542±0.063* 
Thigh adductors 
Adductor longus     1.757±0.406  3.325±0.576* 
Adductor magnus & brevis    0.727±0.078  0.926±0.105 
Gracilis     0.269±0.042  0.506±0.122* 
Pectineus     0.262±0.063  0.376±0.092 
 
 
 
 
Vascular conductance (ml/min/100g/mmHg) measured during submaximal treadmill exercise in all hindlimb muscles of 
rats fed a diet supplemented with Safflower Oil and Fish Oil.  Values are means + SE.  *P< 0.05 compared to SO. 
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Figure 4-1 Splanchnic Blood Flow 
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Blood flow to the splanchnic organs measured at rest (upper panel) and during submaximal treadmill exercise (lower 
panel) in rats fed a diet supplemented with Safflower Oil (Control) and Fish Oil.  *P< 0.05. 
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Figure 4-2 Bulk Hindlimb Blood Flow 
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Blood flow to the total hindlimb musculature measured at rest (upper panel) and during submaximal treadmill 
exercise (lower panel) in rats fed a diet supplemented with Safflower Oil (Control) and Fish Oil.  *P< 0.05. 
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Figure 4-3 Muscle Blood Flow and Vascular Conductance 
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Blood flow (upper panel) and vascular conductance (lower panel) measured during submaximal treadmill exercise in 
muscles for which there was an effect of Fish Oil.  *P< 0.05. 
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Figure 4-4 Splanchnic Vascular Conductance 
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Vascular conductance to the splanchnic organs measured at rest (upper panel) and during submaximal treadmill 
exercise (lower panel) in rats fed a diet supplemented with Safflower Oil (Control) and Fish Oil.  *P< 0.05. 
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Figure 4-5 Bulk Hindlimb Vascular Conductance 
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Vascular conductance to the total hindlimb musculature measured at rest (upper panel) and during submaximal 
treadmill exercise (lower panel) in rats fed a diet supplemented with Safflower Oil (Control) and Fish Oil.  *P< 0.05.
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CHAPTER 5 - Discussion 
The principal original finding of the present investigation is that 6 weeks of dietary FO 
supplementation with DHA and EPA enhances Q& m to the total hindlimb during locomotory 
treadmill exercise and that this enhancement occurs in both oxidative and glycolytic muscle fiber 
types.  Furthermore, this effect occurred in the absence of changes in mean arterial pressure, as 
demonstrated by the increased VC, suggesting that the effects of PUFAs were manifested in the 
peripheral vasculature.  Our findings agree with previous findings in healthy humans which 
demonstrated that dietary FO supplementation with DHA and EPA enhanced both Q&  and 
conductance in the conduit brachial artery during rhythmic handgrip exercise (47).  Our 
investigation is the first, however, to demonstrate that dietary FO supplementation with DHA 
and EPA enhances Q&  and VC within and among exercising locomotory skeletal muscles.  This is 
significant because enhanced Q&
 
in the conduit arteries would not be anticipated to enhance Q& m 
without a concurrent increase in conductance in the resistance arteries and arterioles, which was 
demonstrated conclusively in the present investigation.  
Potential Mechanisms  
A potential mechanism by which DHA and EPA may have exerted their effects on Q& m is 
by enhanced release of NO from the vascular endothelium.  NO is an endogenous signaling 
molecule that is synthesized by NOS from the vascular endothelium (eNOS) and also the 
sarcolemma of skeletal muscle (nNOS) (45).  When activated, eNOS initiates a cascade of 
reactions in smooth muscle via cyclic GMP (cGMP) and protein kinase which acts to reduce the 
intracellular calcium concentration and decrease calcium-dependent phosphorylization of smooth 
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muscle myosin regulatory light chain thereby relaxing vascular smooth muscle.  DHA and EPA 
supplementation increase acetylcholine-induced NO-dependent relaxation, eNOS mRNA, eNOS 
expression, cGMP levels, and consequently the bioavailability of NO by ~90% in the aorta of 
Sprague-Dawley rats (28, 29).  Therefore, it appears that these PUFAs can enhance dilation in 
the conduit vessels during exercise by means of the NO/cGMP system (21).  The effects of 
PUFAs on the NO/cGMP system are pertinent to this investigation because endothelial NO 
production can be increased in response to the increased shear stress of the flowing blood on the 
vessel walls during exercise (36, 41).  Moreover, previous work from our laboratory has shown  
regional hindlimb Q&  is attenuated in response to eNOS inhibition with L-NAME during 
submaximal treadmill exercise (20 m/min, 10% grade, ~65% V. O2max)(19), thus indicating the  
 
important contribution of NO to Q& m during exercise in the rat.  Therefore, given the important 
role of NO in the regulation of Q& m during exercise, enhanced bioavailability of NO is a likely 
candidate for the increased Q& m seen subsequent to PUFA supplementation in our investigation. 
Interestingly, most of the literature has focused on the effects of PUFAs on NO derived 
from the endothelium (eNOS).  However, the intramuscular location of the neuronal isoform of 
NOS (nNOS) at the sarcolemma and neuromuscular junction has led to speculation that it could 
diffuse out to smooth muscle cells in the adjacent vasculature, bind to soluble guanylyl cyclase 
and initiate the cGMP relaxation cascade that is seen with eNOS (16,26).  In support of this 
notion, specific blockade of nNOS has been shown to attenuate exercise hyperemia in humans 
(18). Similar findings were reported in eNOS knockout mice, where nNOS was implicated in the 
vasodilation of the vasculature of contracting glycolytic skeletal muscle (16).  However, to our 
knowledge, the effects of PUFAs specifically on nNOS has not been investigated.  Therefore, if 
DHA and EPA exert similar effects on nNOS in the skeletal muscle as they do eNOS in the 
 30 
endothelium, enhanced nNOS activity/expression could represent another potential mechanism 
by which DHA and EPA could elevate Q& m during exercise. 
eNOS is expressed primarily in type I, red, oxidative skeletal muscle (19), whereas nNOS 
is expressed to a greater extent in type II, white, glycolytic muscle (45).  eNOS inhibition causes 
a greater attenuation of Q&
 
in the individual muscles composed of oxidative versus glycolytic 
fibers  during treadmill running (19).  Therefore, it was expected that DHA and EPA would exert 
their effects primarily on the muscles composed of oxidative fibers, where eNOS is 
predominantly expressed in the vasculature, resulting in greater increases in Q&  within those 
muscles.  Interestingly, the results of the present investigation revealed increased Q&  in muscles 
composed of both oxidative and glycolytic (i.e. low oxidative) fibers.  Thus, if DHA and EPA do 
act to increase nNOS activity/expression, this may be responsible for the unexpected increase in 
Q& m that we found in muscles composed of glycolytic (low oxidative) fibers.   
Another potential mechanism by which DHA and EPA may have enhanced Q& m and 
conductance is via the enhanced release of prostaglandins.  Enhanced release of both 
prostacyclin (PGI2) and prostaglandin I3 (PGI3) has been demonstrated subsequent to PUFA 
supplementation (20).  The vascular endothelium produces PGI2 and PGI3 in response to 
exercise-induced elevation of shear stress (15), and the release of prostaglandins does contribute 
to the regulation of Q& m at the onset of exercise (11, 50).  Additionally, the combined effects of 
prostaglandins and NO have been demonstrated to contribute substantially to brachial artery Q&
 
during exercise in humans (43).  Therefore, if PUFA supplementation can enhance endothelial 
release of both prostaglandins and NO, there exists the potential that both may have contributed 
to the enhanced Q& m and VC seen in this investigation.  
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Another potential factor that may have been responsible for the enhanced Q& m following 
DHA and EPA supplementation is a reduction in vascular oxidative stress.  Oxidative stress is a 
condition in which excess reactive oxygen species (ROS) overwhelm the cells’ antioxidant 
systems and exert deleterious effects on the vascular endothelium including impaired 
vasodilation (46).  Recent evidence indicates that PUFAs can decrease the production of the 
ROS superoxide (O2-) (6).  Similar findings have been shown in type-2 diabetic and fructose-fed 
rats (33, 37).  Additionally, DHA and EPA enhance superoxide dismutase (SOD) activity in the 
rat (7).  These findings are significant because excess superoxide can react with endogenous NO 
to generate other ROS such as peroxynitrite (ONOO-), which exerts pernicious effects on 
endothelial function.  Conversely, SOD can also convert O2- to hydrogen peroxide (H2O2), a 
more stable ROS, that can subsequently be converted to H2O by catalase or glutathione 
peroxidase.  Consequently, if DHA and EPA reduce O2- production and increase SOD activity, 
they could potentially have a positive (lower oxidative state) impact on the redox state in the 
vasculature.  Specifically, reductions in oxidative stress might well improve endothelium-
dependent vasodilation in the exercising musculature and contribute to the mechanistic bases for 
the effects of DHA and EPA on Q& m in this investigation.   
Dietary supplementation with DHA and EPA also increases muscle sympathetic nerve 
activity (MSNA) during exercise, at least in humans (32) which should cause a decrease in both 
Q& m and conductance in the exercising muscle.  As previously mentioned, however, DHA and 
EPA supplementation have been able to enhance brachial artery diameter and Q&  during exercise 
(47).  This contradiction may be explained by the ability of DHA and EPA to increase NO 
bioavailability as described above, thereby increasing endothelium-dependent vasodilation and 
simultaneously attenuating alpha-adrenergic vasoconstriction in exercising skeletal muscle, a 
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process termed sympatholysis (4, 8, 42).  Therefore, increased NO production or availability 
subsequent to DHA and EPA supplementation may be responsible for the enhanced Q& m and VC 
seen in the face of increased MSNA. 
Significance 
Our results have shown that DHA and EPA significantly enhance bulk hindlimb Q& m and 
VC during submaximal treadmill exercise in the absence of significant changes in mean arterial 
pressure.  Therefore, DHA and EPA increased O2 delivery to the hindlimb musculature during a 
given level of submaximal exercise.  The significance of these findings lies in the ability of 
increased O2 delivery to raise microvascular and intracellular O2 levels in the working muscles 
and in so doing reduce the degree of metabolic perturbation within the myocytes at a given level 
of exercise.  This could be expected to delay the onset of fatigue and allow the individual to 
work at a given intensity for longer durations.  The present investigation demonstrated that 
PUFAs can exert a beneficial effect on Q& m and VC even in a healthy population.  The ability to 
offset fatigue may be more important, however, in a clinical condition such as cardiovascular 
disease.  Cardiovascular diseases such as coronary artery disease, hypercholesterolemia, type II 
diabetes, and hypertension are all characterized by increased vascular resistance and endothelial 
dysfunction during exercise that contribute to a reduced exercise tolerance (23).  Therefore, if 
DHA and EPA can enhance Q& m and VC during exercise in these populations, effective 
application may have profound effects on the quality of life of the affected individuals.  
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Limitations 
The exercise intensity utilized in this investigation was approximately 65% of V
.
O2max 
(19).  This workload was chosen because it limited increases in mean arterial pressure and 
permitted the rats to run without becoming fatigued.  Higher workloads would cause greater 
shear stress and which would potentially enhance release of NO and/or prostaglandins.  
Therefore, the effects DHA and EPA may be even more marked at higher exercise intensities. 
Conclusions 
In conclusion, the present investigation demonstrated that 6 weeks of dietary FO 
supplementation with DHA and EPA significantly enhanced Q& m and VC to the total hindlimb 
musculature during submaximal treadmill exercise.  Additionally, this effect was seen in both 
oxidative and glycolytic muscle fibers and was coincident without increases in mean arterial 
pressure.  Consequently, these findings support the notion that DHA and EPA supplementation 
could enhance exercise tolerance by increasing O2 and substrate delivery to the exercising 
musculature.  
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